mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.05 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.05 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.05 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.05 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.05 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.13 |
0.05 |
mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.06 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |